GLOBUS MEDICAL INC·4

Jun 9, 5:04 PM ET

Davidar David D 4

4 · GLOBUS MEDICAL INC · Filed Jun 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Globus Medical (GMED) Director Davidar David Sells 25,000 Shares

What Happened
Director Davidar David exercised 25,000 stock options and immediately sold 25,000 shares on 2026-06-05. The options were exercised at $26.27 per share (total exercise cost $656,750) and the resulting shares were sold in the open market at a weighted average price of $80.76 per share for total proceeds of $2,019,073. The filing also reports a related derivative disposition (25,000 units at $0), reflecting conversion/disposition of the option instrument. The options were granted January 30, 2017 and are fully vested.

Key Details

  • Transaction date: 2026-06-05; Form 4 filed: 2026-06-09 (timely — within two business days).
  • Exercise: 25,000 options exercised at $26.27/share = $656,750 total.
  • Sale: 25,000 shares sold, weighted average price $80.76/share = $2,019,073 total (sale price range reported $80.59–$80.92).
  • Derivative entry: 25,000 option units reported disposed at $0, reflecting conversion of the options.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: shares sold in multiple trades (weighted avg reported); some shares are held in a trust for the reporting person’s spouse and children (spouse is trustee).

Context
This was an exercise of vested options followed by an immediate sale of the resulting shares — a common practice to realize gains and/or cover exercise costs and taxes. Sales do not necessarily indicate a change in confidence; purchases are generally more informative about bullish insider sentiment. The filing appears timely and includes customary footnotes about the weighted average sale price and trust holdings.

Insider Transaction Report

Form 4
Period: 2026-06-05
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2026-06-05$26.27/sh+25,000$656,750535,175 total
  • Sale

    Class A Common Stock

    [F1]
    2026-06-05$80.76/sh25,000$2,019,073510,175 total
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    [F3]
    2026-06-0525,0000 total
    Exercise: $26.27Exp: 2027-01-30Class A Common Stock (25,000 underlying)
Holdings
  • Class A Common Stock

    [F2]
    (indirect: By Trust)
    165,967
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $80.59 - $80.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.
  • [F2]These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
  • [F3]These options were granted on January 30, 2017 and are fully vested.
Signature
/s/ Kelly G. Huller, Attorney-in-Fact|2026-06-09

Documents

1 file
  • 4
    ownership.xmlPrimary

    4